AnteoTech Limited (ADO.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -5 Million AUD | -92.02% |
| 2023 | -1.41 Million AUD | 84.41% |
| 2022 | -9.06 Million AUD | 54.9% |
| 2021 | -20.11 Million AUD | -553.0% |
| 2020 | -3.07 Million AUD | 27.98% |
| 2019 | -4.27 Million AUD | -28.46% |
| 2018 | -3.32 Million AUD | -2656.49% |
| 2017 | -120.75 Thousand AUD | -103.28% |
| 2016 | 3.68 Million AUD | 171.2% |
| 2015 | -5.17 Million AUD | 26.83% |
| 2014 | -7.07 Million AUD | -169.76% |
| 2013 | -2.62 Million AUD | 46.32% |
| 2012 | -4.88 Million AUD | 28.85% |
| 2011 | -6.86 Million AUD | -381.35% |
| 2010 | -1.42 Million AUD | -49.57% |
| 2009 | -953.35 Thousand AUD | 69.45% |
| 2008 | -3.12 Million AUD | -143.61% |
| 2007 | -1.28 Million AUD | 9.88% |
| 2006 | -1.42 Million AUD | -448.06% |
| 2005 | -259.37 Thousand AUD | 8.48% |
| 2004 | -283.41 Thousand AUD | 72.13% |
| 2003 | -1.01 Million AUD | 70.24% |
| 2002 | -3.41 Million AUD | 36.11% |
| 2001 | -5.34 Million AUD | 3.9% |
| 2000 | -5.56 Million AUD | 11.81% |
| 1999 | -6.31 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -3.64 Million AUD | 0.0% |
| 2024 FY | -2.69 Million AUD | -90.36% |
| 2024 Q4 | -5 Million AUD | 0.0% |
| 2023 Q4 | -1.41 Million AUD | 0.0% |
| 2023 Q2 | -5.21 Million AUD | 0.0% |
| 2023 FY | -1.41 Million AUD | 84.41% |
| 2022 FY | -9.06 Million AUD | 54.9% |
| 2022 Q4 | -9.06 Million AUD | 0.0% |
| 2022 Q2 | -15.45 Million AUD | 0.0% |
| 2021 Q2 | -6.42 Million AUD | 0.0% |
| 2021 FY | -20.11 Million AUD | -553.0% |
| 2021 Q4 | -20.11 Million AUD | 0.0% |
| 2020 FY | -3.07 Million AUD | 27.98% |
| 2020 Q2 | -1.85 Million AUD | 0.0% |
| 2020 Q4 | -3.07 Million AUD | 0.0% |
| 2019 Q2 | -2.3 Million AUD | 0.0% |
| 2019 Q4 | -4.27 Million AUD | 0.0% |
| 2019 FY | -4.27 Million AUD | -28.46% |
| 2018 Q2 | -4.91 Million AUD | 0.0% |
| 2018 FY | -3.32 Million AUD | -2656.49% |
| 2018 Q4 | -3.32 Million AUD | 0.0% |
| 2017 Q4 | -120.75 Thousand AUD | 0.0% |
| 2017 Q2 | -3.4 Million AUD | 0.0% |
| 2017 FY | -120.75 Thousand AUD | -103.28% |
| 2016 Q2 | -3.6 Million AUD | 0.0% |
| 2016 FY | 3.68 Million AUD | 171.2% |
| 2016 Q4 | 22.53 Million AUD | 0.0% |
| 2015 FY | -5.17 Million AUD | 26.83% |
| 2015 Q2 | -6.85 Million AUD | 0.0% |
| 2015 Q4 | -5.17 Million AUD | 0.0% |
| 2014 Q2 | -7.47 Million AUD | 0.0% |
| 2014 FY | -7.07 Million AUD | -169.76% |
| 2014 Q4 | -7.07 Million AUD | 0.0% |
| 2013 Q3 | -2.62 Million AUD | 37.55% |
| 2013 Q2 | -4.19 Million AUD | 0.0% |
| 2013 Q1 | -4.19 Million AUD | 14.04% |
| 2013 FY | -2.62 Million AUD | 46.32% |
| 2013 Q4 | -2.62 Million AUD | 0.0% |
| 2012 FY | -4.88 Million AUD | 28.85% |
| 2012 Q4 | -4.88 Million AUD | 0.0% |
| 2011 FY | -6.86 Million AUD | -381.35% |
| 2011 Q4 | -6.86 Million AUD | 0.0% |
| 2010 Q4 | -1.42 Million AUD | 0.0% |
| 2010 FY | -1.42 Million AUD | -49.57% |
| 2009 FY | -953.35 Thousand AUD | 69.45% |
| 2009 Q4 | -953.35 Thousand AUD | 0.0% |
| 2008 FY | -3.12 Million AUD | -143.61% |
| 2008 Q4 | -3.12 Million AUD | 0.0% |
| 2007 Q4 | -1.28 Million AUD | 0.0% |
| 2007 FY | -1.28 Million AUD | 9.88% |
| 2006 FY | -1.42 Million AUD | -448.06% |
| 2006 Q4 | -1.29 Million AUD | 0.0% |
| 2005 Q4 | -259.37 Thousand AUD | 0.0% |
| 2005 FY | -259.37 Thousand AUD | 8.48% |
| 2004 Q4 | -283.41 Thousand AUD | 0.0% |
| 2004 FY | -283.41 Thousand AUD | 72.13% |
| 2003 FY | -1.01 Million AUD | 70.24% |
| 2003 Q4 | -1.01 Million AUD | 0.0% |
| 2002 FY | -3.41 Million AUD | 36.11% |
| 2002 Q4 | -3.41 Million AUD | 0.0% |
| 2001 Q4 | -5.34 Million AUD | 0.0% |
| 2001 FY | -5.34 Million AUD | 3.9% |
| 2000 FY | -5.56 Million AUD | 11.81% |
| 1999 FY | -6.31 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -491.775% |
| Acrux Limited | -1.45 Million AUD | -243.04% |
| Race Oncology Limited | -17.18 Million AUD | 70.902% |
| Biome Australia Limited | -1.56 Million AUD | -220.035% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 93.694% |
| BTC Health Limited | -2.02 Million AUD | -147.336% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -63.823% |
| CSL Limited | 15.76 Billion AUD | 100.032% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 96.336% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 97.267% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 73.535% |
| Hexima Limited | -2.22 Million AUD | -124.665% |
| Immutep Limited | -122.18 Million AUD | 95.907% |
| Memphasys Limited | 4.13 Million AUD | 220.945% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 70.741% |
| Noxopharm Limited | -2.31 Million AUD | -115.59% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 50.785% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 73.074% |
| Starpharma Holdings Limited | -19.83 Million AUD | 74.781% |
| Tissue Repair Ltd | -16.44 Million AUD | 69.579% |
| Biotron Limited | -386.06 Thousand AUD | -1195.503% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 59.923% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -409.265% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -604.879% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 198.701% |
| Patrys Limited | -2.24 Million AUD | -123.216% |
| Orthocell Limited | -19.92 Million AUD | 74.898% |
| Imugene Limited | -91.56 Million AUD | 94.537% |
| PYC Therapeutics Limited | -65.76 Million AUD | 92.394% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 20.91% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 19.401% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 60.663% |
| Nanollose Limited | -96.22 Thousand AUD | -5097.739% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 16.988% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -0.956% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -174.268% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -303.867% |
| Nyrada Inc. | -4.76 Million AUD | -4.868% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 95.272% |
| Dimerix Limited | -21.99 Million AUD | 77.257% |
| PharmAust Limited | -9.71 Million AUD | 48.513% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 71.552% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -47.271% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 6.149% |
| Actinogen Medical Limited | -9.13 Million AUD | 45.229% |
| Immuron Limited | -11.48 Million AUD | 56.447% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 68.569% |